David Molkentine
机构：The University of Texas MD Anderson Cancer Center, The University of Texas Health Science Center at Houston · ORCID：0000-0003-0505-6815
发表论文 177 篇 · 总被引 1432 次 · h-index 22
代表论文
- KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancer (2025 · Cancer Cell · 被引 20)
- FOXM1-Specific TCR-Engineered T Cells Target Non–Small Cell Lung Cancer (2026 · Cancer Immunology Research · 被引 3)
- Strategies for Overcoming ALK TKI-resistance in ALK-fusion NSCLC (2026 · Digital Commons-TMC (Texas Medical Center))
- Supplementary Figure 1 from FOXM1-Specific TCR-Engineered T Cells Target Non–Small Cell Lung Cancer (2026)
- Supplementary Figure 3 from FOXM1-Specific TCR-Engineered T Cells Target Non–Small Cell Lung Cancer (2026)
- Supplementary Figure 2 from FOXM1-Specific TCR-Engineered T Cells Target Non–Small Cell Lung Cancer (2026)